Risk factors for Clostridium difficile-associated diarrhea and the effectiveness of prophylactic probiotic therapy

Author： Mizui T.   Teramachi H.   Tachi T.   Tamura K.   Shiga H.   Komada N.   Umeda M.   Koda A.   Aoyama S.   Goto C.   Tsuchiya T.  

Publisher： Govi-Verlag

ISSN： 0031-7144

Source： Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol.68, Iss.8, 2013-08, pp. : 706-710

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

New agents for Clostridium difficile-associated disease

By Guiles Joseph   Critchley Ian   Sun Xicheng  

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 11, 2008-11 ,pp. : 1671-1683

Informa Healthcare

Access to resources Recommend Favorite

Clostridium difficile infection

By Clark Tristan   Wiselka Martin  

Clinical Medicine, Vol. 8, Iss. 5, 2008-10 ,pp. : 544-547

Royal College Of Physicians

Access to resources Recommend Favorite

Therapy of Clostridium difficile infection: perspectives on a changing paradigm

By Tran Mai-Chi N   Claros Marina C   Goldstein Ellie J C  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 17, 2013-12 ,pp. : 2375-2386

Informa Healthcare

Access to resources Recommend Favorite

Emerging therapies for Clostridium difficile infections

By McFarland Lynne V  

Expert Opinion on Emerging Drugs, Vol. 16, Iss. 3, 2011-09 ,pp. : 425-439

Informa Healthcare

Access to resources Recommend Favorite

Prevention and treatment of Clostridium difficile infection

By Gouliouris Theodore   Brown Nicholas M   Aliyu Sani H  

Clinical Medicine, Vol. 11, Iss. 1, 2011-02 ,pp. : 75-79

Royal College Of Physicians

Access to resources Recommend Favorite